A native of Innsbruck, Austria, Klaus Lindpaintner graduated from the University of Innsbruck Medical School with a degree in Medicine and from Harvard University with a degree in Public Health. He pursued postgraduate training and specialization in Internal Medicine, Cardiology, and Genetics in the United States and Germany and holds board certifications these specialties.

He practiced cardiology and pursued research in the area of cardiovascular disease and molecular genetics and genetic epidemiology, most recently as an Associate Professor of Medicine at Harvard Medical School in Boston, Massachusetts.

He joined Hoffman-La Roche Pharmaceuticals in Basel in 1997 as Head of Preclinical Research in Cardiovascular Diseases. Since 1998, he has served as Head of Roche Genetics, and since 2001, also as Director of the Roche Center for Medical Genomics, coordinating the company′s efforts and activities in genetics, genomics, proteomics, and associated disciplines.

He has co-authored more than 200 scientific papers, holds an honorary and adjunct professorship at University of London and Shanghai Jiao Tong University, served/s on several public panels on genetics and society (STRATA-EU, CIOMS-WHO, Nuffield Council for Bioethics, OECD WG on Pharmacogenetics, EFPIA WG on Pharmacogenetics), as well as on the editorial boards of several scientific journals.

Klaus Lindpaintner lives near Basel, Switzerland; he is married to an internist, and has two daughters.

F. Hoffmann-La Roche Ltd.
Roche Molecular Medicine Laboratories
Bldg. 93 / 804B
4070 Basel
Switzerland

Phone: +41 61 688 19 79
Fax: +41 61 688 19 29
klaus.lindpaintner@roche.com
www.roche.com